1. Withania somnifera (Ashwagandha)-related liver injury

   News item 23 September 2023 Pages: 1 - 1

2. AstraZeneca COVID-19 vaccine-related pityriasis rosea

   News item 23 September 2023 Pages: 2 - 2

3. AstraZeneca COVID-19 vaccine-related retinal vein occlusion

   News item 23 September 2023 Pages: 3 - 3

4. Clonidine may cause serious adverse events in children

   News item 23 September 2023 Pages: 4 - 4

5. FDA changes therapeutic equivalence rating for Accord Healthcare's tacrolimus

   News item 23 September 2023 Pages: 5 - 5

6. FDA issues warning letters about unapproved eye disorder therapies

   News item 23 September 2023 Pages: 6 - 6

7. Infusion-related reactions, allergic or pseudo-allergic, potentially serious

   Media release 23 September 2023 Pages: 7 - 7

8. Vanishing bile duct syndrome due to drug-induced liver injury

   News item 23 September 2023 Pages: 8 - 8

9. Acetylcholinesterase inhibitor-related psychiatric AEs

   Clinical study 23 September 2023 Pages: 9 - 9

10. ADHD therapy medication errors in paediatric patients

    Clinical study 23 September 2023 Pages: 10 - 10

11. Infigratinib-related adverse events

    Clinical study 23 September 2023 Pages: 11 - 11

12. Pegcetacoplan-related injection site reactions do not reduce compliance

    Clinical study 23 September 2023 Pages: 12 - 12

13. Other adverse reaction research

    News item 23 September 2023 Pages: 13 - 13

14. Acetazolamide/carbamazepine

    Case report 23 September 2023 Pages: 14 - 14

15. Aciclovir/dexamethasone/ganciclovir

    Case report 23 September 2023 Pages: 15 - 15

16. Adalimumab/prednisolone-acetate/triamcinolone

    Case report 23 September 2023 Pages: 16 - 16

17. Afatinib

    Case report 23 September 2023 Pages: 17 - 17

18. Albutrepenonacog-alfa

    Case report 23 September 2023 Pages: 18 - 18

19. Alectinib/lorlatinib/osimertinib

    Case report 23 September 2023 Pages: 19 - 19

20. Allopurinol

    Case report 23 September 2023 Pages: 20 - 20

21. Allopurinol

    Case report 23 September 2023 Pages: 21 - 21

22. Alprazolam

    Case report 23 September 2023 Pages: 22 - 22

23. Amantadine

    Case report 23 September 2023 Pages: 23 - 23

24. Amantadine

    Case report 23 September 2023 Pages: 24 - 24

25. Amiodarone

    Case report 23 September 2023 Pages: 25 - 25

26. Amisulpride/olanzapine

    Case report 23 September 2023 Pages: 26 - 26

27. Amisulpride/olanzapine/risperidone

    Case report 23 September 2023 Pages: 27 - 27

28. Amitriptyline/fluoxetine/phentermine

    Case report 23 September 2023 Pages: 28 - 28

29. Amoxicillin/amoxicillin/clavulanic-acid

    Case report 23 September 2023 Pages: 29 - 29

30. Andexanet-alfa/rivaroxaban

    Case report 23 September 2023 Pages: 30 - 30

31. Antiasthmatics/ketamine/magnesium-sulfate

    Case report 23 September 2023 Pages: 31 - 31

32. Antibacterials

    Case report 23 September 2023 Pages: 32 - 32

33. Antibiotics

    Case report 23 September 2023 Pages: 33 - 33

34. Antidepressants/linezolid

    Case report 23 September 2023 Pages: 34 - 34

35. Antiepileptic drugs/pyridoxine

    Case report 23 September 2023 Pages: 35 - 35

36. Antifungals/hydroxychloroquine/prednisone

    Case report 23 September 2023 Pages: 36 - 36

37. Antihypertensives/phenoxybenzamine/spironolactone

    Case report 23 September 2023 Pages: 37 - 37

38. Antineoplastic drugs

    Case report 23 September 2023 Pages: 38 - 38

39. Antineoplastics

    Case report 23 September 2023 Pages: 39 - 39

40. Antineoplastics

    Case report 23 September 2023 Pages: 40 - 40

41. Antineoplastics

    Case report 23 September 2023 Pages: 41 - 41

42. Antineoplastics

    Case report 23 September 2023 Pages: 42 - 42

43. Antineoplastics

    Case report 23 September 2023 Pages: 43 - 43

44. Antineoplastics

    Case report 23 September 2023 Pages: 44 - 44

45. Antineoplastics

    Case report 23 September 2023 Pages: 45 - 45

46. Antineoplastics

    Case report 23 September 2023 Pages: 46 - 46

47. Antineoplastics/immunosuppressants

    Case report 23 September 2023 Pages: 47 - 47

48. Antipsychotics

    Case report 23 September 2023 Pages: 48 - 48

49. Antipsychotics

    Case report 23 September 2023 Pages: 49 - 49

50. Antipsychotics/levodopa/rasagiline

    Case report 23 September 2023 Pages: 50 - 50